Carcinoma, Non-Small Cell Lung Clinical Trials in Seongnam
2 recruitingSeongnam, South Korea
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Carcinoma, Non-Small Cell Lung
Eli Lilly and Company700 enrolled353 locationsNCT06890598
Recruiting
Phase 1
A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors
Carcinoma, Non-Small Cell LungCarcinoma, HepatocellularNeoplasms+1 more
Aptamer Sciences, Inc.70 enrolled4 locationsNCT06687941